Are Chemokines Stored for Regulated Secretion in Rodent Endothelial Cells? by Wilhelmsen, Linn
Thesis for the Master’s degree in Molecular Biosciences  
   
 
 
 
 
 
 
 
Linn Wilhelmsen 
 
Are Chemokines Stored for Regulated 
Secretion in Rodent Endothelial Cells? 
 
 
 
 
     
       60 study points 
 
 
 
      Department of Molecular Biosciences 
      Faculty of mathematics and natural sciences 
      UNIVERSITY OF OSLO 03/2008  
 
 
 2 
 
Acknowledgement 
This work has been carried out in the Laboratory of Immunohistochemistry and 
Immunopathology (LIIPAT), Institute of Pathology, Rikshospitalet University Hospital, 
University of Oslo, 2006-2008. 
First I would like to express my gratitude to Dr. Guttorm Haraldsen, for giving me the 
opportunity to work at his lab, for introducing me to the exciting field of endothelial 
cells and for always being an enthusiastic and inspiring supervisor. Also thanks to Prof. 
Oddmund Bakke for giving me the opportunity to do this thesis and for the 
administration help. 
Further, I would like to thank my co-supervisor Johanna Hol for being the wonderful 
co-worker and pedagogical supervisor through my work at the laboratory and the 
process of writing this thesis. You have had an amazing patience, always been there to 
answer my questions and ask the right questions back to me. Last but not at least you 
have been a good friend. 
To all the members at the VEC group, thank you so much for all the fun, the friendly 
work environment, technical guidance and scientific advice. You are all wonderful 
people. 
And to the girls at Blindern; Anja, Cathrine, Kristine, Miriam, and Tine, thank you for 
giving me the warm welcome when I started my degree, you`ve made my schoolwork a 
lot more fun.  
Thanks to all the members of LIIPAT, technical staff as well as researchers and 
administration. It has truly been exciting to take part in a pulsating and inspiring 
research environment.  
Further, I would like to thank Camilla, my office mate through this year. We`ve had 
such a good time in “Genistallen”, giving eachother motivation and inspiration, and 
shearing the ups and downs that research is all about. 
Finally, I would like to thank my mom who always encourages and believes in me, my dad 
for being supporting and caring, and the rest of my family and friends for reminding 
me that there is more to life than science.  
 
Oslo, March 2008 
 
Linn Wilhelmsen 
  3 
Table of contents 
ABBREVIATIONS..................................................................................................................................... 5 
SUMMARY ................................................................................................................................................. 6 
1. INTRODUCTION............................................................................................................................ 7 
1.1 THE LEUKOCYTE ADHESION CASCADE ......................................................................................... 7 
1.2 CHEMOKINES ................................................................................................................................. 9 
1.2.1 Chemokine receptors ....................................................................................................... 11 
1.2.2 ELR+ chemokines in mice and men ............................................................................... 12 
1.2.3 Chemokine clusters .......................................................................................................... 13 
1.3 THE SECRETORY PATHWAY - REGULATED AND CONSTITUTIVE SECRETION ............................. 15 
1.3.1 The Weibel-Palade Body ................................................................................................. 15 
1.3.2 Other compartments for regulated secretion in endothelial cells ................................ 16 
2. METHODOLOGICAL BACKGROUND ................................................................................. 17 
2.1 IMMUNOHISTOCHEMISTRY.......................................................................................................... 17 
2.1.1 Antibodies......................................................................................................................... 17 
2.1.2 Controls ............................................................................................................................ 18 
2.1.3 Fixation ............................................................................................................................ 18 
2.1.4 Antigen Retrieval (AR) .................................................................................................... 19 
2.1.5 Animal models.................................................................................................................. 19 
3. AIMS ................................................................................................................................................ 21 
4. MATERIALS AND METHODS ................................................................................................. 22 
4.1 MATERIALS.................................................................................................................................. 22 
4.2 METHODS..................................................................................................................................... 23 
 4 
4.2.1 Human tissue ....................................................................................................................23 
4.2.2 DSS-model of colitis.........................................................................................................23 
4.2.3 CLP model of peritonitis and sepsis ...............................................................................24 
4.2.4 Tissue processing and histology......................................................................................24 
4.2.5 Immunostaining and Antigen Retrieval ..........................................................................25 
4.2.6 Microscopy .......................................................................................................................27 
5. RESULTS ........................................................................................................................................28 
5.1.1 IL-8 can be detected in formalin-fixed samples of human intestine .............................28 
5.1.2 Robust detection of ELR+ CXC chemokines in rodent vessels requires non-biotin 
amplification of the signal ...............................................................................................................28 
5.1.3 CXCL1 is induced in vessels of inflamed intestine: .......................................................32 
5.1.4 Immunostaining for CXCL6 ............................................................................................35 
5.1.5 CXCL6 is not found on endothelial cells in rodents ......................................................35 
6. DISCUSSION..................................................................................................................................38 
7. CONCLUSION ...............................................................................................................................41 
8. REFERENCES ...............................................................................................................................42 
 
  5 
Abbreviations 
A    Absorbance 
Ab  Antibody 
AR  Antigen Retrieval 
Ag  Antigen 
CD  Crohn`s Disease 
CLP  Cecal ligation and puncture 
DSS  Dextran Sulphate Sodium 
EC  Endothelial cell 
GCP-2  Granulocyte Chemotactic protein 
HEV  High endothelial venule 
HRP  Horseradish Peroxidase 
HUVEC Human umbilical vein endothelial cell 
IBD  Inflammatory Bowel Disease 
IHC  Immunohistochemistry 
IL  Interleukin 
kDa  kilo Daltons 
KLH  Keyhole-Limpet Hemocyanin 
mAb  Monoclonal Antibody 
MIP-2  Macrophage inflammatory protein 2 
PBS  Phosphate-buffered saline 
RT  Room temperature 
TNF  Tumor necrosis factor 
UC  Ulcerative Colitis 
vWf  von Willebrand factor 
WPB  Weibel-Palade bodies 
 6 
Summary 
Chemokines are small, secreted proteins (5-15 kDa) that mediate leukocyte 
transmigration and can be secreted from endothelial cells in a constitutive or 
regulated manner. Regulated secretion shortens the response time to inflammatory 
stimuli because the chemokine is produced in advance and not dependent on de novo 
synthesis. The existence of regulated chemokine secretion from endothelial cells has 
not yet been demonstrated in animal models. A homologue of the potent neutrophil-
attracting chemokine IL-8 has not been found in rodents. However, other potent 
neutrophil chemoattractants such as CXCL1, CXCL2, and CXCL6 were therefore 
analyzed by immunohistochemistry in experimental acute peritonitis/sepsis and in 
DSS-induced colitis, with special emphasis on their possible sorting to Weibel-Palade 
bodies (WPB). The data presented imply that sorting to WPB for regulated 
chemokine secretion is not a prominent feature of rodent endothelial cells but also 
indicate that MIP-2 may be sorted to another granular compartment in resting 
mesenteric vessels, perhaps related to the type II compartment of regulated secretion 
recently described in human endothelial cell cultures  
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1. Introduction 
The inside of blood vessels is lined with endothelial cells that constitute the interface 
between circulating blood and surrounding tissues. Here they provide a tightly 
controlled barrier that regulates recruitment of leukocytes to the underlying tissues, 
vascular tone and hemostasis. Depending on their location within the vasculature, 
endothelial cells have distinct gene expression profiles in healthy individuals [1], [2]. 
Moreover, their phenotype is dramatically altered when exposed to proinflammatory 
or immunoregulatory cytokines as well as other humoral mediators [3]. 
During normal bloodflow, red and white blood cells generally travel along the central 
axis, leaving a cell-poor layer of plasma in contact with endothelium. As vascular 
permeability increases in early inflammation, fluid exits the vascular lumen and blood 
flow slows down. As a result, the leukocytes settle out of the central column, 
marginating to the vessel periphery. The identity of emigrating leukocytes varies 
depending on the nature of the inciting stimulus, and also changes as the 
inflammatory site ages. Thus, in most forms of acute inflammation, neutrophils 
predominate for the first 6-24 hours and are followed by monocytes in the subsequent 
24 to 48 hours. This pattern is best explained by the sequential expression of different 
adhesion molecules and chemotactic factors as detailed below [4] 
1.1 The leukocyte adhesion cascade 
The recruitment of leukocytes from the blood to surrounding tissues takes place in 
lymphoid organs and in inflammatory lesions in a multistep process. It is mainly 
initiated by selectins which enable tethering and rolling of leukocytes along the 
endothelial cell surface until chemokines or other chemoattractants trigger firm arrest 
and enable trans-endothelial migration [5]. P-selectin and E-selectin are expressed by 
inflamed endothelial cells and interacts with PSGL1 (P-selectin glycoprotein ligand 
1) found on the leukocyte microvilli [6]. L-selectins is expressed by most leukocytes 
 8 
and interacts with PNAd (peripheral lymph node addressin) in high endothelial 
venules (HEVs) as well as with less characterized glycosylated ligands on inflamed 
venules. The interaction of selectins with their ligands is characterized by 
exceptionally high on- and off-rates which determine the speed with which bonds are 
formed and broken respectively [6]. Selectin-mediated leukocyte rolling allows 
activating signals to be transmitted through selectins or selectin-ligands but a crucial 
event appears to be the activation of leukocytes via G protein-coupled receptors by 
chemokines or other chemoattractants presented on the endothelial cell surface. Upon 
such activation leukocyte arrest is rapidly triggered via integrins that change their 
conformation to an activated state and then bind to immunoglobulin superfamily 
members expressed by endothelial cells, such as ICAM1 and VCAM1 [7]. Resting 
vessels are thought to have neither selectins, their ligands nor other chemoattractants 
on their surface. Moreover, immunoglobulin superfamily members are expressed at 
low levels and the absence of chemoattractants does not allow substantial integrin 
activation. The resting endothelial cell phenotype will therefore not permit a strong 
flux of leukocytes across the vessel wall. During inflammation, on the other hand, 
endothelial cells are activated by bacterial products such as LPS (lipopolysaccharide) 
or inflammatory cytokines to enhance the expression of adhesion molecules and to 
induce synthesis of chemokines and lipid chemoattractants for presentation on their 
luminal surface.  
Although resting endothelial cells display no early adhesion determinants on their 
surface, they have an excellent system to allow rapid activation and recruitment of 
neutrophils. Firstly, they sort P-selectin to Weibel-Palade bodies (described in more 
detail below) that can be rapidly translocated to the surface membrane upon exposure 
to mast cell-derived histamine, coagulation-induced thrombine or complement-
derived C5a. Secondly, the WPB also contains the chemokine IL-8 and eotaxin-3, but 
so far such sorting has been observed only in human tissues and cell culture models 
[8], [9]. Of relevance to this thesis, endothelial cells can also by means of transcytosis 
from their abluminal surface to the lumen present chemokines that are made by 
perivascular cells [10] [11]. 
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1.2 Chemokines 
Chemokines are small proteins (5-15 kDa) that play a fundamental role in the 
development and homeostasis of the immune system as well as in immune responses 
[12]. Chemokines are also involved in angiogenesis and tumorigenesis [13]. During 
host responses against infections, the subtle interplay between chemokines and 
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adhesion molecules allows specific leukocyte subsets that express corresponding 
chemokine receptors to be selectively recruited to the site of inflammation.  
Based on the position of the first two out of four conserved cysteine residues, 
chemokines can be classified into two major subgroups; CC chemokines and CXC 
chemokines. The nomenclature is defined by the structure-related acronyms followed 
by an L (for ligand) and the number of their gene. Earlier designations involved 
consecutively numbered genes that were designated as SCY (small inducible 
cytokines). In addition, most chemokines have names based on their initially 
observed functions and the discovering laboratory, in many cases also leading to 
different names in different species. For example, CXCL1 is known as Gro, KC or 
CINC in human, mouse and rat, respectively (see table 1) [14]. 
Table 1 - Chemokine nomenclature in human, mouse and rat 
Chemokine 
Nomenclature 
Human Mouse Rat 
CXCL1 Gro- KC CINC 
CXCL2 Gro- MIP-2 MIP-2 
CXCL6 GCP-2 GCP-2/LIX LIX 
CXCL8 IL-8 Has not been 
described 
Has not been 
described 
 
The CXC chemokine family can be further divided based on the presence or absence 
of the amino acid sequence Glu-Leu-Arg (ELR) immediately preceding the two N-
terminal cysteine residues. ELR
+
 CXC chemokines are predominantly activators of 
neutrophilic granulocytes and the ELR motif is indispensable for this chemotactic 
activity. Moreover, the ELR motif also appears to discriminate angiogenic (ELR
+
) 
from angiostatic (ELR
-
) CXC chemokines [15]. Like cytokines, chemokines are 
proteins produced by leukocytes and tissue resident cells, either constitutively or after 
activation. They act locally in a paracrine or autocrine fashion. The chemokines are 
usually much smaller than cytokines and act via heptahelical G-protein coupled 
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receptors, a feature common to several types of leukocyte attractants [16]. Through 
interactions with specific G-protein-coupled seven-transmembrane receptors, 
chemokines induce intracellular signalling leading to integrin activation during 
leukocyte adhesion (see above), oxidative burst, release of lysosomal enzymes and 
chemotaxis. 
 
 
1.2.1 Chemokine receptors 
The receptors are defined by the chemokines structure-related acronyms such as 
CXC, CC, XC and CX3C, followed by R and a number [14]. Six CXC chemokine 
receptors, and 10 CC chemokine receptors, as well as receptors for lymphotactin 
(XCR1) and fractalkine (CX3CR1), have been identified to date. Most receptors 
recognize more than one chemokine and several chemokines bind to more than one 
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receptor [16]. Chemokines can synergize with each other or with other inflammatory 
mediators to enhance leukocyte infiltration in an early phase.  
1.2.2 ELR+ chemokines in mice and men 
Seven different ELR+ chemokines that all attracts neutrophils have been identified in 
man (Figure 3). Of these, IL-8/CXCL8 and GCP-2/CXCL6 are by far the most 
efficient and are found in large amounts in acute inflammatory lesions. A particular 
feature of IL-8 is that it signals predominantly through the chemokine receptor 
CXCR1 whilst the effects of most other ELR+ chemokines are mediated mainly via 
CXCR2 or via CXCR2 alone. Of special interest to this study is that a homologue of 
IL-8 is missing in rodents. Other potent neutrophil chemoattractants exist in the 
mouse, such as KC/CXCL1, MIP-2/CXCL2, GCP-2/CXCL6, Thymus chemokine-
1/CXCL7 and CXCL15/lungkine. Moreover, a rodent homologue of the main IL-8 
receptor, CXCR1, has recently been cloned and characterized [17, 18] and on the 
grounds of GCP-2 being the only other chemokine apart from IL-8 to signal 
efficiently via CXCR1 [18], it was of additional interest to assess whether GCP-2 like 
IL-8 can be sorted to Weibel Palade bodies for regulated secretion.  
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1.2.3 Chemokine clusters 
Chemokines differ in their biological activity, regulation of expression, receptor-
binding specificities and the chromosomal location of the genes that encode them. In 
addition to the classification of chemokines based on structure (e.g. CC vs CXC 
chemokines), they also fall into two major groups based on their expression patterns 
and functions: those that are expressed in inflammation and therefore called 
inflammatory chemokines, and those that are constitutively expressed in discrete 
locations of the immune system, called homeostatic chemokines. Moreover, the 
genomic organization of chemokines enables us to divide chemokines into two 
alternative groups: those whose genes are located in large clusters at particular 
chromosomal locations and the non-cluster or mini-cluster chemokines whose genes 
are located separately in unique chromosomal locations. There are four major clusters 
of chemokine genes, two which are among the CXC chemokines plus numerous non-
clustered or mini-cluster genes in both the human and the mouse genomes. The 
explanation for this dispersion is the force of evolution. Once duplication occurs, the 
two copies evolve independently and develop unique and specialized functions. The 
members of a given gene cluster usually bind to multiple receptors and vice versa. 
Furthermore, cluster chemokines often do not correspond well between species, for 
example between human and mouse [19] [20]. An explanation for the large number 
of ligands for these receptors may be that, during inflammation, multiple chemokines 
are needed to induce a robust leukocyte response [21]. Moreover, differential 
expression of these chemokines among different tissues may finally orchestrate the 
recruitment of leukocytes to the tissues and by this enable a customization of the 
inflammatory responses. Most cluster chemokines belong to the inflammatory 
category of chemokines [20, 21].  
Table 2 The chemokine superfamily
Human
Other
names Chromosome Function Cluster Mouse
Other
names Chromosome Function Cluster Receptor
CXC family
CXCL1 Gro 4q13.3 I GRO CXCL1 Gro/KC 5qE2 I GRO CXCR2, CXCR1
CXCL2 Gro 4q13.3 I GRO CXCL2 MIP-2 5qE2 I GRO CXCR2
CXCL3 Gro 4q13.3 I GRO Gm1960 Dcip1 5qE2 I GRO CXCR2
CXCL4 PF4 4q13.3 U GRO CXCL4 PF4 5qE2 U GRO CXCR3B^
CXCL4VI 4q13.3 U GRO
CXCL5 ENA-78 4q13.3 I GRO CXCL5 LIX* 5qE2 I GRO CXCR2
CXCL6 GCP-2 4q13.3 I GRO LIX*
CXCL7 NAP-2 4q13.3 I GRO CXCL7 Ppbp 5qE2 I GRO Unknown
CXCL8 IL-8 4q13.3 I GRO Unknown CXCR1, CXCR2
CXCL9 MIG 4q21.1 I IP10 CXCL9 MIG 5qE3 I IP-10 CXCR3, CXCR3B
CXCL10 IP-10 4q21.1 I IP10 CXCL10 IP-10 5qE3 I IP-10 CXCR3, CXCR3B
CXCL11 I-TAC 4q21.1 I IP10 CXCL11 I-TAC 5qE3 I IP-10 CXCR3, CXCR3B, CXCR7
CXCL12 SDF-1/ 10q11.21 H CXCL12 SDF-1/ 6qF1 H CXCR4, K61CXCR7
CXCL13 BLC, BCA-1 4q21.1 H IP10 CXCL13 BLC, BCA-1 5qE3 H IP-10 CXCR5
CXCL14 BRAK, Bolekine 5q31.1 I CXCL14 BRAK 13qB2 I Unknown
Unknown CXCL15 Lungkine, Weche 5qE2 U Unknown
CXCL16 DMC 17q13.2 I CXCL16 CXCL16 11qB4 I CXCR6
CXCL17 19q13.2 U CXCL17 DMC 7qA3 U Unknown
CC family
CCL1 I-309 17q11.2 I MCP CCL1 TCA-3 11qB5 I MCP CCR8
CCL2 MCP-1 17q11.2 I MCP CCL2 JE 11qB5 I MCO CCR2
CCL3 MIP-1, LD78 17q11.2 I MIP CCL3 MIP-1 11qB5 I MIP CCR1, CCR5
CCL3L1 LC78 17q12 I MIP
CCL3L3 LC78 17q13 I MIP
CCL4 MIP-1 17q14 I MIP CCL4 MIP-1 11qB5 I MIP CCR5
CCL4L1 AT744.2 17q15 I MIP
CCL4L2 17q16 I MIP
CCL5 RANTES 17q17 I MIP CCL5 RANTES 11qB5 I
CCR1, CCR3, 
CCR5
CCL7 MCP-3 17q11.2 I MCP CCL7 MARC 11qB5 MCP
CCR1, CCR2,
CCR3
CCL8 MCO-2 17q11.2 I MCP CCL8, CCL
MCP-2
MCP-5 11qB5 I MCP
CCR1, CCR2, 
CCR3, CCR5
CCL11 Eotaxin 17q11.2 I MCP CCL11 Eotaxin 11qB5 I MCP CCR3
CCL13 MCP-4 17q11.2 I MCP Unknown MCP
CCR1, CCR2, 
CCR3  
CCL14 HCC-1 17q12 H MIP Unknown CCR1
CCL15 HCC-2 17q12 H MIP CCL19
MMRP2, CCF18
MIP-1 11qB5 H MIP CCR1, CCR3
CCL16 HCC-4 LEC 17q12 H MIP Pseudogene 11qB5 MIP
CCR1, CCR2,
CCR5, HRH4
CCL17 TARC 16q13 D MIP CCL17 TARC 8qC5 D CCR4
CCL18 PARC 17q12 H Pseudogene Unknown
CCL19 MIP3, ELC 9p13.3 H CCL19 MIP3 4qB1 H CCR7
CCL20 MIP3, LARC 2q36.3 D CCL20 MIP3, LARC 1qC5 D CCR6
CCL21 SLC 9p13.3 D
CCL21a, 
CCL21b,
CCL21c SLC 4qB1 D CCR7
CCL22 MDC 16q13 D CCL22 ABCD-1 8qC5 D CCR4
CCL23 MPIF-1 17q12 I MIP CCL6 C10 11qB5 I MIP CCR1, FPRL-1
CCL24 Eotaxin-2 7q11.23 I CCL24 Eotaxin 2 5qG1 I CCR3
CCL25 TECK 19p13.3 H CCL25 TECK 8qA1.2 H CCR9
CCL26 Eotaxin 3 7q11.23 I CCL26l Eotaxin 3-like 5qG1 I CCR3
CCL27 CTACK, ILC 9p13.3 H CCL27a, b CTACK, ILC 4qB1 H CCR10
CCL28 MEC 5p12 U CCL28 MEC 13 U CCR10, CCR3
Other classes
XCL1 Lymphotactin 1q24.2 D XC11 Lymphotactin 1qH2 D XCR1
XCL2 SCM-1 1q24.2 D
CX3Cl1 Fractalkine 16q13 I CX3C11 Fractalkine 8qC5 I XC3CR1
Functions are as follows: I, inflammatory, H, Homeostatic, D, dual (homeostatic and inflammatory), U, unknown. The list of alternative names are not comprehensive. Chromosomal location data are 
derived from the Ensebl (39) or Mouse Genome Informatics (40) databases. GRO, GRO region of the CXC major gene cluster, IP10, IP10 region of the CXC major gene cluster. MIP, MIP region of the 
CC major gene cluster. Adapted from Zlotnik, Genome Biology 2006; 7:243. *CXCL5 and CXCL6 appear to have originated from the common ancestor LIX by gene duplication, see discussion.
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1.3 The secretory pathway - regulated and constitutive secretion 
Eukaryotic cells are highly compartmentalised into distinct membrane-bound 
organelles. The organelles of the secretory pathway are involved in sorting of 
proteins to a variety of intracellular membrane compartments and to the cell surface.  
The fusion of secretory vesicles with the plasma membrane occurs in all cells as 
constitutive exocytosis, and is required for the insertion of new cell membrane. 
Moreover, many extracellular molecules like plasma proteins and antibodies are 
secreted by the constitutive secretory pathway [22]. On the other hand, regulated 
secretion is a process in which the organelles with their cargo reside in the cytoplasm 
until the cell receives a second stimulus inducing fusion of the organelle with the 
plasma membrane and release of its cargo [23]. Chemokines can be secreted both in a 
constitutive and in a regulated manner [8]. 
1.3.1 The Weibel-Palade Body 
The best characterized intracellular storage pools in endothelial cells are Weibel-
Palade Bodies (WPB). They are rod-shaped, elongated structures that appear like 
“chocolate sprinkles” in the cytoplasm [24], [25].  The major constituent of WPB is 
the multimeric protein von Willebrand factor (VWF), which is required for correct 
hemostasis at sites of vascular injury through its role in platelet adhesion. Several 
lines of evidence support the idea that VWF is the driving force behind the biogenesis 
of these organelles. Expression of VWF in nonendothelial cells results in the 
formation of VWF-containing, rod-shaped organelles that closely resemble WPB. 
Over the past few years it has been appreciated that multiple components are stored 
together with VWF in WPB. The growing list of components that are present within 
this subcellular organelle suggests a role for regulated release of WPB in 
inflammation, hemostasis and angiogenesis [24], [25]. Several studies have provided 
evidence for the existence of different subsets of WPB that apart from VWF do not 
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contain the same set of additional constituents. A clear example is the neutrophil-
attracting chemokine IL-8. This chemokine is stored in WPB only after induction of 
its synthesis by inflammatory mediators such as IL-1, thus providing a rapidly 
releasable pool of IL-8, independent of de novo synthesis [8]. Up to this date there are 
12 proteins in addition to VWF that have been identified as constituents of WPB [26].  
1.3.2 Other compartments for regulated secretion in endothelial cells 
More recently, another granular compartment in vascular endothelial cells containing 
the chemokines GRO/CXCL1 and MCP-1/CCL2 was discovered in vascular 
endothelial cells. Based on the absence of other proteins known to reside in similar 
granules as well as differential responsiveness to cAMP and PKC mimetics it was 
designated, the type II compartment of regulated secretion in endothelial cells [27]. In 
this manner, prestored chemokines can originate from different compartments for 
rapid release and presentation upon demand, allowing rapid recruitment of leukocytes 
in acute inflammation [8].  
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2. Methodological background 
2.1 Immunohistochemistry 
Immunochemistry started in 1941, when it was realized that antibodies could be 
labelled with fluorescent molecules and at the same time preserve their binding 
activity. Accordingly, immunohistochemistry is an antibody-based technique that 
allows the scientist to study epitope distribution in tissues. Such analyses can be 
performed using fluorochrome- or enzyme-conjugated antibodies. The latter will 
generate a coloured precipitate from a chromogenic substrate. While an advanced 
fluorescence-microscope is needed to observe fluorochromes, a light microscope is 
sufficient when using enzyme conjugated antibodies. The validity and quality of 
immunohistochemistry depends on the antibody quality, how the tissue is fixed and 
processed, the unmasking of epitopes and the sensitivity of the detection system [28]. 
Like other antibody-based techniques, immunohistochemistry requires careful 
selection and titration of antibodies and the use of appropriate controls. Complete and 
regularly updated websites of commercially available antibodies, reagents and kits 
are for example The Linscotts Directory (http://www.linscottsdirectory.com) and the 
Biocompare website (http://www.biocompare.com/index.asp) 
2.1.1 Antibodies 
Primary antibodies that give unwanted background sometimes make it necessary to 
block the tissue sections with serum from the species of the secondary antibody 
before applying the primary antibody. If non-specific background persist, further 
dilution of the primary antibody combined with an increase in the concentration of 
secondary reagents is often effective. If there is cross-reactivity between the 
secondary antibody and antigens present in the target cells or tissue, this is often 
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caused by cross-reaction with immunoglobulins in the target tissues, and such binding 
can be reduced by pre-absorbing the antibody with serum from the target species.  
2.1.2 Controls 
Proper controls must always be included with each staining procedure. Either 
preimmune serum or isotype- and concentration-matched Ig should be used as a 
negative control to ensure that the staining observed is not due to background, and a 
positive control slide should always be included to verify the activity of the 
secondary reagents. One slide that omits a primary antibody is also useful to indicate 
background associated with the secondary antibody. Given that antibodies raised to 
peptide fragments are often linked to keyhole limpet hemocyanine (KLH) as a 
hapten, an optimized control for such reagents would be an antibody purified from 
immunoserum by means of KLH alone.  
2.1.3 Fixation 
The fixation of tissues is required to stop diffusion of soluble components, block 
unwanted enzyme activity, stop degradation of tissue structures and allow the 
preparation to withstand the different steps of the staining procedure [29]. Acetone is 
a gentle fixative used mainly after cryopreservation, and causes minimal antigenic 
denaturation, sufficient membrane permeabilization for antibodies to enter the cells 
and in many cases an acceptable morphology. Formalin- or paraformaldehyde-fixed 
tissue retains excellent morphology, but the antigen often suffers extensive 
denaturation that may diminish or completely prohibit epitope recognition by the 
primary antibody. This problem can be solved via two approaches; either by using 
antibodies that have been raised to specifically recognize formalin-fixed antigens 
and/or using a protocol designed to expose antigens in fixed tissues, such as the 
method of antigen retrieval (see below) [30]. 
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2.1.4 Antigen Retrieval (AR) 
Formalin forms intra-molecular crosslinks with amino groups of proteins and can 
therefore influence the accessibility of the antigen for an antibody. Heat treatment is 
the most commonly used method used for the antigen retrieval in 
immunohistochemical studies of formalin-fixed and paraffin-embedded tissues. Heat 
treatment cleaves the formalin-induced intra- and intermolecular crosslinks of 
proteins [31]. In addition to the temperature, pH and buffer composition are important 
parameters that contribute to proper AR. Therefore, several different buffers at 
specific pH should be tested to find the most optimal AR procedure for your antigen 
of interest. After AR, the antibody might need to be re-titrated properly, since more 
epitopes becomes available after the AR treatment. The potential disadvantages using 
AR are detrimental effects on tissue morphology and increases the general 
background staining. 
2.1.5 Animal models 
It is important to have animal models that closely simulate human disease. The model 
of cecal ligation and puncture (CLP) in rodents has been used to investigate the 
clinical conditions of sepsis and septic shock. Aspects of sepsis research using the 
CLP-model include, among others, immune function, mediator release and cytokine 
expression patterns [32], and CLP represents a good model for acute systemic 
inflammation. The driving agents of inflammation in the CLP model are bacterial 
products that leak into the peritoneal cavity and are recognized by the host immune 
system, leading to the release of proinflammatory cytokines  
Dextran Sulphate Sodium (DSS) -induced colitis is another widely used model in 
rodents. It simulates human inflammatory bowel disease (IBD), and is a useful model 
of chronic inflammation [33]. It is popular because it is reproducible and easy to 
induce: it involves cheap, easily maintained, and widely available animal species: it 
has a predicable time course of inflammation and it resembles the clinical course, 
therapeutic response and inflammatory mediator profile of human IBD [33]. The 
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most severe disease in this model takes place in the distal colon, where a mixed cell 
inflammatory infiltrate comprising lymphocytes, macrophages and granulocytes 
develops. High levels of ELR
+
 chemokines have been reported in both clinical sepsis 
and IBD as well as in rodent CLP and DSS model systems. The DSS model has 
proved particularly useful for testing epithelial repair agents, and has also been used 
for testing inhibitors of TNF, IL-18 and IL-1 [34-36]. Considering the availability of 
these models, we chose to use these model systems to study the expression of ELR
+
 
chemokines. 
Bacterial products such as LPS from gram negative bacteria are powerful activators 
of Toll-like receptors (TLR) that induce the release of inflammatory cytokines via 
activation of nuclear factor (NF)-B. Intestinal epithelial cells are the first line of 
defense against invasion of intestinal bacteria. LPS also stimulates the release of IL-8 
from these cells. The release of these inflammatory cytokines and NF-B activation 
in macrophages and intestinal epithelial cells plays a key role in the pathology of 
inflammatory bowel disease (IBD), such as ulcerative colitis (UC) and Crohn`s 
disease (CD) [37] They are characterized by chronic inflammation and a constant 
influx of leukocytes out of the blood stream into the mucosa, mediated by pro-
inflammatory cytokines and chemokines [38].  
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3. Aims 
• Establish whether formalin-fixed, paraffin-embedded tissue is suitable for 
detection of vessel-associated chemokines 
• Establish protocols for detection of rodent ELR+ chemokines in tissue sections 
• Assess the vascular expression of such chemokines in healthy and inflamed 
tissue 
• Establish whether such chemokines are sorted to Weibel-Palade bodies of 
rodents for regulated secretion in vivo. 
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4. Materials and Methods 
4.1 Materials 
Table 3 - Primary antibodies 
Mouse anti-human IL-8 LeukoSite Inc, Cambridge 
MA 
1 g/ml 
Rabbit anti-human VWF Dako, Glostrup Denmark 1:2000 
Rabbit anti-mouse KC Peprotech EC LTD, London 1 g/ml 
Rabbit anti-mouse MIP-2 Peprotech EC LTD, London 1 g/ml 
Rabbit anti-human GCP-2 Peprotech EC LTD, London 5 g/ml 
Rabbit anti-mouse LIX Peprotech EC LTD, London 1 g/ml 
1 
2 
3 
4 
5 
6 
7 
TRITC-conjugated, goat 
anti-human VWF  
Unknown 1:100 
8 Rabbit anti-hemocyanin Sigma, Missouri USA Matched to the test 
antibody 
 
Table 4 - Secondary and tertiary reagents 
1 Biotinylated horse anti-mouse IgG  Vector Laboratories, 
Burlingame USA 
1:200 
2 Streptavidin Cy2  Amersham Biosciences, 
GE Healthcare, Oslo 
Norway 
1:1000 
3 Cy3-conjugated donkey anti-rabbit 
IgG 
Jackson ImmunoResearch 
Laboratories, West Grove 
USA 
1:500 
4 HRP-conjugated donkey anti-mouse 
IgG  
Jackson ImmunoResearch 
Laboratories, West Grove 
USA 
1:300 
5 HRP-conjugated goat anti-rabbit IgG Invitrogen Molecular 
Probes 
1:100 
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Table 5 - Other reagents  
 
 
4.2 Methods 
4.2.1 Human tissue 
Sections of biopsy material taken from human non-inflamed colon were retrieved 
from the Diagnostic Biobank at the Division of Pathology according to a protocol 
approved by the regional Committee for Research Ethics (S-05152). 
4.2.2 DSS-model of colitis 
Intestinal samples from DSS-fed mice were kindly provided by Anders Sandvik, 
Institute. of Pathology, UiO). To induce colitis these animals were given DSS, (MP 
Biomedicals, Inc. Solon, Ohio, USA) dissolved in the drinking water (1.5% w/v) for 
7 days according to a protocol approved by the national ethics committee for animal 
experiments. Control animals were given regular drinking water. Following a 
recovery phase of 4 days animals were anesthetized by subcutaneous injection of 
Hypnorm® and Midazolam (50-75L/10g body weight) prior to cardiac puncture. 
Postmortem mice were soaked in 70% ethanol and fixed to a dissection board. The 
abdomen was opened and the colon excised, before flushing with cold PBS and 
partitioning into proximal, middle, and distal segments prior to fixation. All tissue 
samples were kept on ice and fixed in 4 % formalin for 24 h at 4°C before transfer to 
PBS with 0.1% formalin for storage at 4°C or immediate tissue processing. 
TSA kit Invitrogen Molecular Probes 1 
2 H2O2 Ventana Medical Systems, France 
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4.2.3 CLP model of peritonitis and sepsis 
Intestinal samples from adult Wistar male rats with peritonitis caused by cecal 
ligation and puncture (CLP), were kindly provided by J.E. Wang and Y.Y. Wang. 
CLP was performed by a method described elsewhere (Irshad Chaudry, 1979), using 
isoflurane anesthesia and buprenorphin (Temgesic, Schering Plough International, 
Kenilworth, NJ, US) to provide analgesia. The rats were fasted for 16 hours before 
anaesthesia, with water allowed ad libitum. The abdomen was opened and the colon 
exposed. The cecum was ligated just below the ileocecal valve to maintain bowel 
continuity and punctured twice with an 18 Gauge needle before closing the 
abdominal wall in two layers. Sham animals were subjected to surgery, but not CLP. 
Animals were given 3ml/100g body weight physiological saline subcutaneously 
immediately after and 12 hours after surgery to compensate for loss of fluid. Animals 
were sacrificed after 24 hours and an array of tissues excised and transferred to 
fixative as described for the mouse samples. 
4.2.4 Tissue processing and histology 
Biopsies were embedded in paraffin using an automated tissue processor (Leica 
TP1050, Leica Instruments GmbH, Nussloch, Germany) and cut in 4 m sections that 
were arranged onto polysine-coated microscope slides, incubated at 60°C for 30 
minutes and cooled. To remove paraffin from the tissue surface, tissue sections were 
incubated in xylene, rehydrated in a serial grade of absolute, 95%, and 70% ethanol 
(15 seconds each) and finally washed in PBS (2 x 2 minutes).  
Haematoxylin and eosin staining (H&E) is the most commonly used tissue staining 
for animal histology and routine pathology. The basic dye, haematoxylin, gives a 
purplish blue stain to basophilic structures, such as nuclei, ribosomes and rough 
endoplasmic reticulum due to their content of DNA and RNA, respectively. By 
cont5rast, eosin/azophloxin is an acidic dye that stains eosinophilic structures, such as 
most cytoplasmic proteins, pinkish red. A particular feature of the H&E staining 
protocol at the Division of Pathology is the addition of saffron to also stain 
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connective tissue orange [39]. The staining is performed as follows; Deparaffinised 
tissue sections are dipped in ddH2O before incubation in haematoxylin (10 minutes), 
hexamine (2 minutes), azophloxin (3 minutes) and in saffron (3 minutes). Between 
each step, the slide is cleansed under running tap water. The tissue is then dehydrated 
in absolute alcohol (2 x 2 minutes) and mounted in Eukitt. 
4.2.5 Immunostaining and Antigen Retrieval 
Antigenic epitopes masked by formalin-fixation were retrieved by incubation in pre-
heated Tris-buffer (pH 9.0) for 20 minutes on a water bath at 100°C, followed by 
cooling to room temperature in the same buffer. To determine the localization of the 
different chemokines, different methods of immunolabelling were used, each time 
validating the specificity of the labelling by means of concentration-matched 
irrelevant antibodies. Immunohistochemistry can be performed as a direct method, in 
which the primary antibody is conjugated, and the staining is performed in one 
operation, or as an indirect method, in which the primary antibody is un-conjugated 
and the secondary antibody is conjugated. If the secondary antibody is polyclonal, 
several secondary antibodies can bind each primary antibody. This makes the indirect 
method more sensitive than the direct method. The use of biotin-avidin interactions is 
another popular approach based on the extremely high binding affinity between 
molecules, and the ability of one biotin molecule to bind four streptavidin molecules. 
Multiparameter immunohistochemistry allows the simultaneous detection of different 
epitopes by carefully selecting primary and secondary reagents that do not cross-react 
and by labelling each epitope with fluorochrome-conjugates of one specific colour. 
In one series of experiments, human IL-8 was detected by mixing mouse anti-human 
IL-8 together with rabbit anti-human VWF in in PBS containing 1.25% BSA and 
incubating sections over night at 4°C. The sections were washed in PBS (2 x 3 
minutes) before applying a mixture of biotinylated horse anti-mouse and Cy3-
conjugated donkey anti-mouse antibody and incubating for 1.5 hour at RT. The 
washing procedure was repeated and tertiary Cy2 conjugated streptavidin was applied 
and incubated for another 1.5 hour. Finally, slides were washed as described above, 
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counterstained with Hoechst nuclear dye, and washed once in ddH2O before 
mounting with polyvinyl alcohol (PVA) 
Another series of experiments employed tyramide signal amplification (TSA
TM
), an 
enzyme-mediated detection method that utilizes the catalytic activity of horseradish 
peroxidase (HRP) to generate high-density labelling of a target.  TSA-labelling 
combines three elementary processes: 
1. Binding of a primary antibody to the target followed by secondary detection of 
the probe with an HRP-labelled antibody or a streptavidin conjugate.  
2. Activation of multiple copies of a dye- or hapten-labelled tyramide derivative 
by HRP 
3. Covalent coupling of the resulting highly reactive, short-lived tyramide 
radicals to nucleophilic residues in the vicinity of the HRP-target interaction 
site, resulting in minimal diffusion-related loss of signal localization.  
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When using the Tyramide Signal Amplification Kit, endogenous peroxidase activity 
was quenched with H2O2 for 10 minutes at RT. The specimens were then blocked 
with 1% blocking buffer for 60 minutes. Primary antibody was diluted together with 
TRITC-conjugated goat anti-human VWF in 1% blockingbuffer and incubated over 
night at 4°C. The secondary HRP conjugate (Jackson Immunoresearch Laboratories, 
West Grove PA or Invitrogen Molecular Probes) was applied and incubated for 2 
hours at RT. After the antibody incubation the slides were washed 2 x 3 minutes with 
PBS, before incubation 10 minutes at RT in tyramide solution prepared according to 
the protocol from the manufacturer (Invitrogen Molecular Probes). The sections were 
protected from light at all times. Finally, slides were washed as described above, 
counterstained with Hoechst nuclear solution, and washed once in ddH2O before 
mounting in PVA. 
4.2.6 Microscopy 
To study the localization of chemokines and to compare it to that of WPB as 
demonstrated by staining for VWF, the immunostained tissues were examined with a 
Nikon E-800 fluorescence microscope or a Zeiss Axioplan Imaging LSM 5 Pascal 
confocal laser scanning microscope.  
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5. Results  
5.1.1 IL-8 can be detected in formalin-fixed samples of human intestine 
Colocalization of IL-8 and VWF has previously been demonstrated in cryopreserved 
sections of human intestine [8]. Due to the excellent morphology provided by 
formalin-fixation, the question was raised whether these findings could be reproduced 
after such fixation, given the risk that the antigen retrieval might cause soluble 
chemokines to detach from the tissue sections. As demonstrated in figure 5, IL-8 was 
indeed detectable by immunofluorescence in formalin-fixed tissue, and colocalization 
with VWF in WPB could be observed. Moreover, this protocol also allowed us to 
observe IL-8 in a pattern compatible with its binding to the surface membrane of 
endothelial cells (data not shown). We therefore concluded that formalin-fixation of 
tissues would facilitate the detection of chemokines under conditions of superior 
morphology. 
5.1.2 Robust detection of ELR
+
 CXC chemokines in rodent vessels requires non-biotin 
amplification of the signal 
Initial efforts to detect chemokines in rodent tissue by modifying the 
biotin/streptavidin protocol used to detect human IL-8, revealed that rodent tissue 
contained high amounts of endogenous biotin rendering them less suitable for this 
method of signal amplification. A commercially available kit for signal enhancement 
based on the tyramide signal amplification protocol was therefore tested and 
established, revealing strong induction of chemokines as described below. To 
investigate the endothelial cell expression of CXCL1, CXCL2 and CXCL6 in 
rodents, suitable models of inflammation were needed. It was desirable to find 
models in which the global expression of these chemokines had been previously 
described, and in which they are presumed to play an important role in the 
pathogenesis. The DSS colitis model and the CLP model appeared to fulfil both of  
IL-8 VWF Merged
IL-8 VWF Merged
A B C
D E F
Figure 5 - CXCL8/IL-8 colocalizes with VWF in endothelial cells of healthy human intestine. Immunostainings of intestinal 
vessel for IL-8 in green (A) and VWF in red (B). The merged image of the green and red channel demonstrates colocalization of 
IL-8 and VWF (C). (D-F) Detail of vessel at higher magnification
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these criteria, and the availability of relevantly preserved tissues in our lab provided 
the additional benefit of avoiding unnecessary animal experiments. The first series of 
experiments were focused on the CLP model that initially mimics acute peritonitis as 
puncture of the cecum will release a massive efflux of bacteria into the peritoneal 
cavity. Moreover, this situation rapidly develops into fulminant sepsis. Despite the 
greatly deteriorated condition of these animals after 24 h we observed quite subtle 
histopathological changes in the intestinal samples including moderate numbers of 
inflammatory leukocytes in vessels (fig 7). To complement these acute findings, 
samples of DSS colitis that had been harvested after a period of 7 days of exposure to  
A B
C D
E F
G H
Figure 7 - Light microscopy of formalin-fixed, H&E-stained sections of rat (A-D) and 
mouse (E-H) intestine used for subsequent immunostainings. The images are obtained with 
x10 (A, B, E and F) and x40 (C, D, and G) lenses. H is a closeup image of F. Normal tissue 
architecture is demonstrated in control animals (A, C, E and G). In septic rats that have 
undergone caecal ligation and puncture (B, D), there is an increase in intraluminal leukocytes 
(arrow D), but no marked increase in cells in the lamina propria. In mice with DSS-induced 
ulcerous colitis (F, H) there is a marked increase in cells in the lamina propria, loss of normal 
crypt architecture (arrow F) and some epithelial sloughing.
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DSS followed by 4 days recovery, were also included, revealing a mixed scenario of 
edema, inflammation and tissue regeneration and showing a moderate to massive 
influx of neutrophillic and eosinophillic granulocytes as well as mononuclear cells 
(Fig 7). 
5.1.3 CXCL1 is induced in vessels of inflamed intestine: 
Expression of CXCL1/KC in healthy rat intestine was assessed by means of a double 
staining protocol designed to allow simultaneous detection of chemokine (green) and 
VWF (red). No immunoreactivity was seen in intestinal vessels, but a weak, non-
granular signal was observed in mesenteric vessels (fig 10) in endothelial cells. By 
contrast, inflamed tissue from CLP rats revealed high levels of expression of CXCL1 
(Fig. 8B) above background levels (fig 8C) in both vessels and other cell types. In the 
former, CXCL1 was expressed in a diffuse pattern compatible with a surface 
membrane location, however, areas of enhanced perinuclear signal intensity indicated 
high levels of chemokine in Golgi stacks, reminiscent of the strong chemokine signal 
seen in Golgi stacks in vitro [9]. On the other hand, we observed no granular signal 
that colocalized with VWF and therefore concluded that CXCL1 is not sorted to 
Weibel-Palade bodies. It is also worth mentioning that not all vessels stained positive 
for chemokines, and in fact it appeared that arterioles in fact to have lower levels of 
chemokine expression than venules. The protocol of the present study did not allow 
identification of other CXCL1-positive cells observed but it is likely that dendritic 
cells and macrophages are among such candidates based on published in vivo data 
[40].  
The expression of CXCL1/KC was also investigated in healthy and inflamed intestine 
of DSS-treated mice. While control tissues revealed no immunoreactivity on 
endothelial cells, inflamed samples showed some vascular chemokine expression, but 
fewer vessels with membranous staining than seen in the rat samples, see figure 8. 
Again, CXCL1 was neither seen in a granular pattern nor seen to colocalize with 
VWF. 
CXCL1 vWf (CLP rat)
F
G H I
LKJ
CXCL1 vW(CLP rat)
C
B
Irr. ctrl vWf  
CXCL1 vWf 
(healthy rat)
CXCL1 (CLP rat) vWf  (CLP rat) CXCL1 vWf  (CLP rat)
CXCL1 vWf (DSS mouse)CXCL1 (DSS mouse) vWf  (DSS mouse)
D
E
Irr. ctrl vWf 
(CLP rat)
CXCL1 vWf  
(healthy rat)
A
Figure 8 - Expression of CXCL1/KC in healthy and inflamed intestine. Vessel in the lamina propria 
costained for CXCL1 (green) and VWF (red). Panel A-C shows overview, panel D-F shows details of one 
single vessel and panel G-I shows higher magnification of vessel in CLP rat. Panel J-L shows detail of 
vessel in DSS mouse. 
CFD
E
G H I
LKJ
B
A
CXCL2 vWf  (CLP rat)IgG vWf 
 
(CLP rat)
IgG  vWf 
 
(CLP rat)
CXCL2  vWf 
(healthy rat)
CXCL2(CLP rat) vWf (CLP rat) CXCL2vWf (CLP rat)
CXCL2vWf(DSS mouse)CXCL2 (DSS mouse) vWf (DSS mouse)
CXCL2   vWf 
(healthy rat) CXCL2 vWf (CLP rat)
Figure 9 - Expression of CXCL2/MIP-2 in healthy and inflamed intestine. Vessel in the lamina propria 
costained for CXCL2 (green) and VEF (red). Panel A-C shows overview, panel D-F shows details of one 
single vessel and panel G-I shows higher magnification of vessel in CLP rat. Panel J-L shows detail of vessel 
in DSS mouse. 
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5.1.4 Immunostaining for CXCL6 
The distribution of CXCL2/MIP-2 in healthy rat intestine revealed an interesting 
difference to that of CXCL1. While no immunoreactivity was found in vessels of the 
lamina propria, (Fig 9A+B), larger venules in the mesentery revealed a granular 
signal for CXCL2 that was quite convincingly associated with endothelial cells but 
did not colocalize with VWF (Fig 10). By contrast, the distribution of vascular 
CXCL2 expression in inflammation was quite similar to that of CXCL1 (fig 9 C, F-I) 
and colocalization with VWF was not observed. In the mouse, control intestinal tissue 
revealed no immunoreactivity, while inflamed tissue revealed expression of CXCL2 
on fewer vessels than in the CLP rat (Fig 9J-L).  
5.1.5 CXCL6 is not found on endothelial cells in rodents 
Staining with an antibody to human CXCL6 in healthy intestine was mainly restricted 
to red blood cells in rat and mouse intestine. The staining pattern obtained with the 
antibody to human CXCL6 was so strong that it was hard to ascertain what subset of 
tissue cells might also be stained. However, no colocalization of CXCL6 with VWF 
was observed (fig 11). Moreover, there was no difference in the distribution of 
CXCL6 when comparing healthy and inflamed intestine, data not shown.  
Vein Vein Artery
CXCL1 VWF Hoechst CXCL1 VWF Hoechst CXCL1 VWF Hoechst
CXCL2 VWF Hoechst CXCL2 VWF Hoechst CXCL2 VWF Hoechst
Irr. ctrl VWF Hoechst Irr. ctrl VWF Hoechst Irr. ctrl VWF Hoechst
Figure 10 – Expression of CXCL1 and CXCL2 in mesenteric vessels of the rat. Three colour immunos-
tainings showing chemokine (green), VWF (red) and Hoechst nuclear staining (blue). Panel A-C shows 
expression of CXCL1 in venule (A and B) and artery (C). Panel D-F shows expression of CXCL2 in venule 
(D and E) and artery (F). Panel G-I shows negative control staining with anti-KLH antibody (green) and 
VWF (red). 
hGCP-2 Ab vWf (CLP rat) hGCP-2 Ab vWf (healthy rat)
hGCP-2 Ab  vWf (healthy rat)hGCP-2 Ab  vWf (CLP rat)
A
B
C D
Figure 11 – Immunostaining for CXCL6/GCP-2 in CLP intestine.  Two colour immunostainings with anti 
human GCP-2 (green) and anti-VWF (red), showing positive red blood cells in healthy (A-C) and inflamed (B and 
D) intestine. Scale bars in A and B = 100 µm, scalebars in C and D = 10 µm
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6. Discussion 
The capacity of endothelial cells to prestore chemokines in the same compartments as 
P-selectin has profound implications for the early vascular responsiveness in acute 
inflammation as in this manner, leukocytes can be rapidly recruited without the delay 
of de novo protein synthesis. In principle, regulated secretion of chemokines has been 
conceptually and mechanistically demonstrated in vitro and the immunohistochemical 
analysis of human tissue has brought evidence of its relevance in vivo [8]. 
Nevertheless, functional studies of the rapid release of chemokines from the 
vasculature in vivo has yet to be performed. The present study was therefore 
undertaken to examine whether known ELR
+
 chemokines were subject to such 
sorting in rodents. Such knowledge is the key to design future in vivo studies that 
could assess the relative importance of rapid chemokine release in clinical settings 
such as ischemia/reperfusion injury and acute allergic reactions.  
The relevance of animal models for understanding human chemokines depends 
in part on the extent to which their structures and functions have been conserved in 
evolution. Evolutionary relationships among mouse and human ELR
+
 chemokines are 
not straight forward [41]. In mice, only five neutrophil chemoattracting ELR
+
 
chemokines have been identified; CXCL1/KC, CXCL2/MIP-2, GCP-2/LIX, 
CXCL7/thymus chemokine-1, and CXCL15/lungkine [42]. Based on available 
literature KC, MIP-2 and LIX were chosen as the most likely candidates for playing 
the role in rodent inflammation that IL-8 plays in man [43]  
The data obtained in this study indicate that KC and MIP-2 are not sorted in 
detectable amounts to Weibel-Palade bodies that represent the best characterized 
compartment of regulated secretion in vascular endothelial cells. The antibody to 
GCP-2 used in this study was raised against the human homologue and produced an 
interesting staining pattern that did not fit well with that seen in preliminary 
experiments using an antibody to the murine homologue GCP-2/LIX (see below). It 
is therefore possible that we have not detected true murine GCP-2/LIX and a possible 
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sorting of GCP-2/LIX to WPB has therefore not been formally excluded. It is also 
possible that either of these chemokines are instead subject to regulated secretion 
from the murine counterpart of a non-WPB compartment recently characterized in 
human endothelial cells and shown to contain GRO-, the human homologue of KC 
[9]. Unfortunately, these granules have not been sufficiently characterized to allow 
their specific recognition in tissue sections and the existence of chemokine secretion 
from such granules can hence not be evaluated in rodents. Nevertheless, it will be 
interesting to explore whether the granular pattern of MIP-2 observed in mesenteric 
venules corresponds to the human compartment containing GRO and whether it is 
responsive to secretagogues like histamine. 
Although decisive data regarding regulated chemokine secretion could not be 
obtained in the course of this study, it nevertheless reveals substantial expression of 
KC and MIP-2 on blood vessels in two settings of inflammation. The demonstration 
of KC on vascular endothelial cells has not been demonstrated before, but is well in 
line with in vitro studies [44] and also in situ hybridization data of inflammatory 
lesions [45]. On the other hand, MIP-2 has to the best of our knowledge not been 
demonstrated on vessels in vivo, although in vitro data point to their ability to 
synthesize it. The data therefore needs confirmation in future studies, either by using 
independent antibodies taking possible differences between mouse and rat into 
account, or by using in situ hybridization for detection of mRNA transcripts.  
The relationship between human GCP-2 and murine LIX deserves further discussion: 
In man, IL-8 and GCP-2 signal through the same chemokine receptors  [46, 47] and 
GCP-2 is nearly as potent as IL-8 in recruiting neutrophils [48]. On these grounds and 
because murine LIX was a more potent stimulator of mouse neutrophils than KC and 
MIP-2 [49], it has been assumed that murine LIX might be the strongest candidate to 
compensate for the lack of IL-8 in rodents. Moreover, murine LIX was considered the 
homologue of human GCP-2 because they shares more identical amino acid residues 
than do murine LIX and human ENA-78 [49]. However, Smith et al. demonstrated 
that human GCP-2 and ENA-78 have a very high nucleotide similarity also in non-
coding regions, suggesting that they are the result of an evolutionary recent gene 
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duplication event and that they developed after the phylogenetic branching of rodents 
and primates from a gene that in rodents later evolved into LIX [41]. The 
immunostainings with the antibody to human GCP-2 yielded a strong signal from red 
blood cells. The putative presence of chemokines on red blood cells is no surprise 
given the known broad chemokine binding affinity of the Duffy antigen receptor of 
chemokines (DARC) on these cells [50], but as no differences were seen between 
species or between illness and health. The question was raised if the anti-human 
GCP-2 reagent is suitable for detecting rodent GCP-2/LIX. To clarify that, 
experiments with a recently acquired anti-murine LIX reagent was performed after 
this study was ended. These stainings showed no similarity to the stainings with anti-
human GCP-2 reagent and no conclusion can hence be drawn on the basis of this 
study about the role of LIX in murine inflammation.  
The fact that some chemokine genes exist in one species but not others applies in 
particular to the inflammatory/cluster chemokines. Genes can also be similar in 
different species but they may not be exact structural or functional equivalents. This 
may also explain that KC in the mouse might not be exactly the same as GRO- in 
human, and that MIP-2 in mice might differ from GRO- in human. While the 
discrimination between KC and MIP-2 in murine tissue has been the focus of much 
attention, it has been difficult to distinguish between the expression pattern of GRO- 
and GRO- in human tissue, because specific antibodies to human GRO- have not 
been available.  
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7. Conclusion 
In conclusion, the fact that IL-8 does not yet have a discovered homologue in the 
mouse may implicate certain limitations when using the mouse models to understand 
human inflammatory diseases. However, for most studies this does not exclude the 
mouse as a valid model for human disease. An example of a situation where rodent 
models appear to be of limited value is the assessment of the clinical relevance of 
regulated chemokine secretion, since no convincing sorting to WPB was observed in 
this study. It is nevertheless possible that regulated chemokine secretion in rodents 
originates from the type II granules described in man and their analysis in vivo first 
requires a better phenotypic characterization. Moreover, animal models using 
different species could also have been used in this study, and deserves further focus 
in future work. 
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